Related Experiment Video

Updated: Mar 26, 2026

Murine Model for Parkinson's Disease: from 6-OH Dopamine Lesion to Behavioral Test
08:06

Murine Model for Parkinson's Disease: from 6-OH Dopamine Lesion to Behavioral Test

Published on: January 15, 2010

32.6K

Nigrostriatal denervation sine parkinsonism

Kristoffer Haugarvoll1, Laurence A Bindoff1, Charalampos Tzoulis2

  • 11 Department of Neurology, Haukeland University Hospital, Bergen, Norway 2 Department of Clinical Medicine, University of Bergen, Norway.

Brain : a Journal of Neurology
|January 27, 2016
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

The 6-hydroxydopamine Rat Model of Parkinson's Disease
08:10

The 6-hydroxydopamine Rat Model of Parkinson's Disease

Published on: October 27, 2021

13.5K
Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease
06:45

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease

Published on: October 4, 2021

3.7K

Related Experiment Videos

Last Updated: Mar 26, 2026

Murine Model for Parkinson's Disease: from 6-OH Dopamine Lesion to Behavioral Test
08:06

Murine Model for Parkinson's Disease: from 6-OH Dopamine Lesion to Behavioral Test

Published on: January 15, 2010

32.6K
The 6-hydroxydopamine Rat Model of Parkinson's Disease
08:10

The 6-hydroxydopamine Rat Model of Parkinson's Disease

Published on: October 27, 2021

13.5K
Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease
06:45

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease

Published on: October 4, 2021

3.7K

Related Concept Videos

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

1.3K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

2.4K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.4K
Neural Regulation01:37

Neural Regulation

44.7K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
44.7K

Articles linked to this work by shared authors, journal, and citation graph.

7 Tesla MRI with Quantitative Susceptibility Mapping: qualitative grading and quantitative focal measurements of the substantia nigra as a potential biomarker for Parkinson's disease.

Neuroradiology·2026

Sex-Specific Cognitive Divergence in Parkinson's Disease.

Brain sciences·2026

In vivo mapping of cerebral small-vessel abnormalities in Parkinson's disease patients using USPIO-MRI at 3T.

NeuroImage·2026

Metabolite-Specific Reproducibility of Cerebral 31P-MRS at 3 T: Implications for Clinical Research.

NMR in biomedicine·2026

Parkinson's disease: Individual placebo responses are predicted by baseline expression of a striato-limbic network.

Research square·2026

Comparative transcriptomics reveal molecular convergence and divergence in parkinsonian disorders.

Brain : a journal of neurology·2026

Early sodium channel blocker initiation is associated with better outcomes in KCNQ2 disorders.

Brain : a journal of neurology·2026

Mechanochemical endothelial-astrocyte signalling via Piezo1-Epac1 drives neurovascular injury after stroke.

Brain : a journal of neurology·2026

Adoptive T-cell therapies in neuroinfectious and neuroinflammatory diseases.

Brain : a journal of neurology·2026

Mapping basal ganglia circuitry in altered states of consciousness: from pathology to pharmacology.

Brain : a journal of neurology·2026

Defining the underlying pathology of corticobasal syndrome using clinical features and biomarkers.

Brain : a journal of neurology·2026

Intron retention in health and amyotrophic lateral sclerosis.

Brain : a journal of neurology·2026

Impact of Non-Tobacco Nicotine Dependence on Outcomes Following Arthroscopic Partial Meniscectomy.

Orthopedics·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us